VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
HNGE
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
HNGEHinge Health, Inc.
$114.41$8.9B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksHNGEBalance Sheet

Hinge Health, Inc. (HNGE) Balance Sheet

3Y historyFree accessUpdated daily

Total assets rose to $874.1M in 2026Q3 with only $33.9M of total debt and a debt-to-equity ratio of 0.11, but the current ratio declined from 2.31 in 2025Q1 to 1.04 and the accumulated deficit of -$914.8M persists against $299.4M of equity.

Income StatementBalance SheetCash FlowRatios

HNGE Balance Sheet

Annual statement

HNGE Balance Sheet

Hinge Health, Inc. (HNGE) balance sheet — 3-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23
Total Current Assets567.86M533.9M583.45M529.88M
Cash & Short-Term Investments294.65M363.86M466.57M423.36M
Cash Only211.55M208M300.79M234.95M
Short-Term Investments83.1M155.87M165.79M188.4M
Accounts Receivable148.53M66.06M42.49M46.56M
Days Sales Outstanding51.8441.0239.7358.06
Inventory19.19M15.64M10.87M13.29M
Days Inventory Outstanding70.0448.1444.1949.23
Other Current Assets46.6M57.41M39.59M32.31M
Total Non-Current Assets306.22M210.86M89.81M92.65M
Property, Plant & Equipment47.31M17.35M16.99M22.48M
Fixed Asset Turnover32.12x33.88x22.98x13.02x
Goodwill113.03M64.1M61.61M61.61M
Intangible Assets68.33M2.51M1.81M2.19M
Long-Term Investments347.23M113.17M00
Other Non-Current Assets18.01M13.73M9.41M6.38M
Total Assets874.08M744.76M673.26M622.53M
Asset Turnover1.01x0.79x0.58x0.47x
Asset Growth %45.36%10.62%8.15%-
Total Current Liabilities544.71M362.41M249.3M184.16M
Accounts Payable80.82M000
Days Payables Outstanding64.61---
Short-Term Debt0000
Deferred Revenue (Current)1.52B300.86M217.63M140.47M
Other Current Liabilities011.46M4.16M6.37M
Current Ratio1.04x1.47x2.34x2.88x
Quick Ratio1.01x1.43x2.30x2.81x
Cash Conversion Cycle57.27---
Total Non-Current Liabilities29.95M3.82M7.26M11.1M
Long-Term Debt0000
Capital Lease Obligations37.34M3.82M7.26M11.1M
Deferred Tax Liabilities795K000
Other Non-Current Liabilities0000
Total Liabilities574.66M366.23M256.56M195.25M
Total Debt33.88M8.04M11.07M15.73M
Net Debt-177.68M-199.96M-289.71M-219.22M
Debt / Equity0.11x0.02x0.03x0.04x
Debt / EBITDA0.22x---
Net Debt / EBITDA-1.14x---
Interest Coverage----
Total Equity299.42M378.54M416.7M427.28M
Equity Growth %-72.6%-9.16%-2.48%-
Book Value per Share3.464.635.345.48
Total Shareholders' Equity299.42M378.54M416.7M427.28M
Common Stock0000
Retained Earnings-914.78M-1.05B-522.74M-510.8M
Treasury Stock0000
Accumulated OCI-921K-20K68K60K
Minority Interest0000

Key Metrics

Growth RegimeExpanding
ProfitabilityWeak
Balance SheetHealthy
Cash FlowImproving
Top Statement Risk

Accumulated deficit persists

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Balance Sheet Rebuilding Through Equity Growth

According to recent SEC filings, HNGE's total assets rose from $675.5M in 2024Q4 to $874.1M in 2026Q3 while total liabilities climbed more slowly, suggesting the balance sheet is strengthening as the business scales.

The expansion in assets appears driven by cash build and goodwill additions, with goodwill rising from $64.1M to $113.0M over the most recent quarters. Total liabilities have grown alongside deferred revenue, which increased from $217.6M to $459.2M, indicating that much of the liability growth reflects prepaid customer contracts rather than borrowed funds. This pattern may indicate improving balance sheet quality, though investors should monitor whether acquisition activity continues to add goodwill that carries impairment risk.

Minimal Leverage Keeps Refinancing Risk Low

Based on reported figures, HNGE carried only $33.9M of total debt against $211.6M of cash in 2026Q3, leaving a debt-to-equity ratio of 0.11 that is low relative to most of its healthcare technology peers.

Total debt has declined from $11.1M in 2024Q4 to a peak-period range near $5.9M to $9.0M before rising to $33.9M in the latest quarter, which may reflect a newly drawn facility or lease-related obligations that the data does not itemize. Because leverage remains modest, refinancing pressure appears limited, and cash flow durability is not dependent on debt service. The recent step-up in debt warrants confirmation of its composition in the filing footnotes.

Liquidity Cushion Tied to Working Capital

As reported in financial statements, HNGE's current ratio fell from 2.31 in 2025Q1 to 1.04 in 2026Q3, while cash stood at $211.6M, indicating a thinner short-term buffer than the company held a year earlier.

The decline in the current ratio appears largely attributable to rising deferred revenue, which is a current liability that grew to $459.2M, rather than to a deterioration in cash. Cash of $211.6M still provides meaningful coverage of near-term obligations, but the ratio near 1.0 leaves less slack if billing timing or collections shift. Given that operating cash flow has been positive, investors may view this as a working-capital consequence of prepaid contracts rather than a solvency concern, though this interpretation depends on collection performance.

Deep Accumulated Deficit Shapes Equity Base

Based on reported figures, HNGE's retained earnings stood at negative $914.8M in 2026Q3 against total equity of $299.4M, a deficit that reflects years of cumulative losses despite recent profitability.

The accumulated deficit narrowed from roughly negative $1.1B in 2025 to negative $914.8M, suggesting that recent net income has begun to reduce historical losses, though the 2025Q1 reduction from negative $1.1B to negative $505.6M likely reflects a discrete accounting event rather than operating results. Equity itself has fluctuated between $299.4M and $438.8M over the period, which may reflect buybacks offsetting stock-based compensation issuance. Investors should monitor whether equity continues to be consumed by repurchases faster than it is rebuilt through earnings.

Deferred Revenue Flatters Apparent Balance Sheet Strength

According to recent SEC filings, HNGE's $459.2M of deferred revenue represents a large portion of its $574.7M in total liabilities, meaning the liability base is dominated by obligations to customers rather than financial creditors.

While low debt supports the headline leverage picture, the substantial deferred revenue balance means a meaningful share of reported cash is effectively owed to customers for services not yet delivered. This structure may mean that cash of $211.6M overstates free liquidity if contract servicing costs must be funded before revenue is recognized. The analysis suggests that investors should look through headline solvency metrics to assess how much cash is truly unencumbered.

HNGE — Frequently Asked Questions

Quick answers to the most common questions about buying HNGE stock.

What are the total assets of Hinge Health, Inc. (HNGE)?

As of 2025, Hinge Health, Inc. (HNGE) had total assets of $744.8M including $533.9M in current assets.

How much debt does Hinge Health, Inc. (HNGE) have?

Hinge Health, Inc. (HNGE) carries total debt of $8.0M, offset by $363.9M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Hinge Health, Inc.?

Hinge Health, Inc. (HNGE) has total shareholders' equity (book value) of $378.5M ($4.63 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Hinge Health, Inc.'s current ratio and liquidity?

Hinge Health, Inc. (HNGE) reported a current ratio of 1.47x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.